RoundTable Healthcare Partners said Monday that it has named Kent Davies the CEO of the newly formed RoundTable III Platform Development Corp. Roundtable is providing “substantial” investment capital to the venture. Davies will identify and develop investment opportunities in the medical device market.
RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that Kent J. Davies has been appointed CEO of the newly formed RoundTable III Platform Development Corporation (“RPDC”), a Fund III investment. In this role, Mr. Davies will focus his attention on the identification and development of new investment opportunities in the medical device market. RoundTable has committed to support these new opportunities with the full resources of the firm including substantial investment capital.
Mr. Davies brings nearly twenty-five years of successful operating, general management, and senior leadership experience to RoundTable having served in executive roles with name-brand healthcare companies such as 3M and Kimberly-Clark Corporation during critical periods of growth. Mr. Davies has also held a series of transactional and transformational leadership roles with rapidly growing businesses in the middle-market private equity and restructuring industries. While serving as its CEO, Mr. Davies led the revitalization, performance recovery, and successful sale of Gaymar Industries to Stryker Corporation. He also played an important role in the sale of SterilMed, Inc. to Johnson & Johnson’s Ethicon Endo-Surgery.
“We are delighted to welcome Kent to the RoundTable team,” said Joseph F. Damico, a Founding Partner and Co-Chairman of RoundTable. “Kent is a proven leader with a strong balance of market-facing, operational, financial and transactional skills. He will bring valuable insights to our work in the medical device market, building on RoundTable’s considerable expertise and experience.”
“RoundTable has a tremendous track record of building strategically and operationally stronger businesses,” said Mr. Davies. “They provide their companies with the necessary financial support, relationships, and resources to be successful, which, together, have produced the strong performance of the firm. I look forward to working with the RoundTable team to identify and build an exciting new healthcare platform for their portfolio.”
About RoundTable Healthcare Partners
RoundTable Healthcare Partners, Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the healthcare industry. RoundTable’s investment strategy targets companies in the healthcare industry that fall within the expertise and experience of the firm’s operating principals. RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise. RoundTable currently manages $1.9 billion of capital, and has ten other platform portfolio companies. More information about RoundTable Healthcare Partners and its investments can be found at www.roundtablehp.com.